After a long, strange trip, this CEO is close to taking a psilocybin pill to market

Fonte: Business Insider

A lot is riding on the shoulders of Kabir Nath, the CEO of Compass Pathways. Scott Semler for BICompass Pathways wants to use psilocybin to help people with treatment-resistant depression. Its psilocybin pill, COMP360, could finally be coming to market as soon as next year.

Business Insider

The 'Big Bad Theory'

há 55m

New York Post

College homecoming party turns to chaos as deck collapses, leaving at least 28 people injured

há 1h

International Business Times

Trump Rules Out Immediate Strikes On Iran, But All Belligerents In The Conflict Are Maintaining An Aggressive Posture

há 1h

Fortune

Singapore urges suppliers to ‘honor commitments’, as Indonesia slashes gas exports to the country by 9%

há 1h

Business Insider

Elon Musk’s dust-up with Ukraine on Starlink isn't over yet

há 1h

New York Post

Firehouse Subs co-founder dies after building beloved American sandwich chain with brother

há 3h

Fortune

42% of America’s recent college grads are working jobs that don’t need a degree. From Kathmandu to Paris, young people are taking to the streets

há 3h

Business Insider

Elon Musk says neoclouds are cooked, and SpaceX won't be buying them

há 3h

Business Insider

Families should stockpile 3 days' worth of essentials in today's world of disaster and war, the UK warns

há 3h

Fortune

Biotech firm Rakuten Medical wants to bring its novel ‘lightsaber’ cancer cure to the U.S.

há 4h

New York Post

Florida man convicted of stealing over $760k worth of Tiffany’s jewelry he swallowed

há 4h

New York Post

Rangers bracing to welcome a couple of old pals back to the Garden with Kings

há 4h

New York Post

Gotham’s quest for NWSL Shield comes down to Decision Day

há 4h

New York Post

Knicks’ Andre Drummond bristles after being benched for lack of effort

há 4h

New York Post

Kenneth Walker skips handshakes with ex-Seahawks teammates after getting shut down in Chiefs’ first loss

há 4h